US4826816A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Antihypertensive compounds
Assignee: Merck Sharp & Dohme LLC
•
Filing: 1985-10-04
•
Granted: 1989-05-02
•
Expires: 2005-10-04
Abstract
Abstract Antihypertensive compounds with angiotensin-converting enzyme inhibitory activity and diuretic activity are disclosed. Such compounds are useful in the treatment of cardiovascular disorders, especially hypertension and congestive heart failure, and are useful in the treatment of glaucoma.
Inventors
- 👤 David R. Andrews
- 👤 Federico C. A. Gaeta
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-09 06:57
CPC Classifications
C; C07; C07D; C07D417/00; C07D417/02; C07D417/12; C07C; C07C255/00; C07K; C07K5/00; C07K5/02; C07K5/022; C07K5/0222; A; A61; A61K; A61K38/00; Y; Y10; Y10S; Y10S530/00; Y10S530/80
Claims Analysis
Total Claims: 28
Claim 1
Independent Claim
489 words
A compound represented by the formula ##STR32## and the pharmaceutically acceptable salts thereof, wherein: A is ##STR33## l is 1 or 2; n is 0 or 1; p and q are 0, 1 or 2, provided that in structurces IIb and IIc the sum of p and q is 1 or 2, and that in formula IId, p is not 0; B is --[J]--[L]--[M]--; D is ##STR34## E is --NH--, --O--, --S--, or --CH 2 --; G is --SO 2 --; J is --(CH 2 ) s -- or --((CH 2 ) t --W)--; L is a chemical bond, cis- or trans-lower alkene, lower alkyne, -Z-aryl-, -aryl-Z-, -Z-cycloalkyl-, or -cycloalyl-Z-, wherein aryl is ##STR35## and cycloalkyl is ##STR36## wherein w is 1, 2 or 3; M is --(CH 2 ) u -- or --((CH 2 ) t --X--(CH 2 ) v )--; W is ##STR37## X and Z are independently a chemical bond, ##STR38## s, u and v are independently 0-5; t is 1-5; R 1 , R 2 and R 9 are independently hydrogen, lower alkyl or lower acyl; R 3 is 2-, 3- or 4-pyridylloweralkyl, 2-, 4- or 5-thiazolylloweralkyl, 2-, 4- or 5-1H-imidazolylloweralkyl, 1-imidazolylloweralkyl, 1-morpholinoloweralkyl or hydroxyphenylloweralkyl; R 4 is chlorine or CF 3 ; R 5 is hydrogen, halogen, lower alkyl, lower acyl, lower alkoxy, haloloweralkyl or phenylloweralkyl; R 7 is hydrogen, lower alkyl or aminoloweralkyl; R 6 and R 8 are independently hydroxy, alkoxy having from 1 to 8 carbon atoms, benzyl, allyl, R 10 --Q r --(CH 2 ) m --O--, wherein Q is oxygen or sulfur, r is 0 or 1 and m is 2 to 4, ##STR39## wherein the alkyl has from 3 to 8 carbon atoms, ##STR40## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR41## R 10 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 11 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 12 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenyl lower alkyl, wherein phenyl may be substituted by group T; R 13 is hydrogen or lower alkyl; and provided that if L is alkene or alkyne, J is --(CH 2 ) s -- wherein is 1-5; provided that if L is --Z--aryl-- or --Z--cycloalkyl--, J is --(CH 2 ) s -- wherein s is 2-5; provided that if L is alkene, alkyne, --aryl--Z-- or --cycloalkyl--Z--, M is --(CH 2 ) u -- wherein u is 1-5; provided that if s and u are each zero, L is aryl or cycloalkyl (i.e. Z is a bond); and provided that if s and v are each zero, L is aryl or cycloakyl (i.e. Z is a bond).
Claim 2
Dependent Claim
489 words
A compound represented by the formula ##STR32## and the pharmaceutically acceptable salts thereof, wherein: A is ##STR33## l is 1 or 2; n is 0 or 1; p and q are 0, 1 or 2, provided that in structurces IIb and IIc the sum of p and q is 1 or 2, and that in formula IId, p is not 0; B is --[J]--[L]--[M]--; D is ##STR34## E is --NH--, --O--, --S--, or --CH 2 --; G is --SO 2 --; J is --(CH 2 ) s -- or --((CH 2 ) t --W)--; L is a chemical bond, cis- or trans-lower alkene, lower alkyne, -Z-aryl-, -aryl-Z-, -Z-cycloalkyl-, or -cycloalyl-Z-, wherein aryl is ##STR35## and cycloalkyl is ##STR36## wherein w is 1, 2 or 3; M is --(CH 2 ) u -- or --((CH 2 ) t --X--(CH 2 ) v )--; W is ##STR37## X and Z are independently a chemical bond, ##STR38## s, u and v are independently 0-5; t is 1-5; R 1 , R 2 and R 9 are independently hydrogen, lower alkyl or lower acyl; R 3 is 2-, 3- or 4-pyridylloweralkyl, 2-, 4- or 5-thiazolylloweralkyl, 2-, 4- or 5-1H-imidazolylloweralkyl, 1-imidazolylloweralkyl, 1-morpholinoloweralkyl or hydroxyphenylloweralkyl; R 4 is chlorine or CF 3 ; R 5 is hydrogen, halogen, lower alkyl, lower acyl, lower alkoxy, haloloweralkyl or phenylloweralkyl; R 7 is hydrogen, lower alkyl or aminoloweralkyl; R 6 and R 8 are independently hydroxy, alkoxy having from 1 to 8 carbon atoms, benzyl, allyl, R 10 --Q r --(CH 2 ) m --O--, wherein Q is oxygen or sulfur, r is 0 or 1 and m is 2 to 4, ##STR39## wherein the alkyl has from 3 to 8 carbon atoms, ##STR40## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR41## R 10 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 11 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 12 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenyl lower alkyl, wherein phenyl may be substituted by group T; R 13 is hydrogen or lower alkyl; and provided that if L is alkene or alkyne, J is --(CH 2 ) s -- wherein is 1-5; provided that if L is --Z--aryl-- or --Z--cycloalkyl--, J is --(CH 2 ) s -- wherein s is 2-5; provided that if L is alkene, alkyne, --aryl--Z-- or --cycloalkyl--Z--, M is --(CH 2 ) u -- wherein u is 1-5; provided that if s and u are each zero, L is aryl or cycloalkyl (i.e. Z is a bond); and provided that if s and v are each zero, L is aryl or cycloakyl (i.e. Z is a bond).
Claim 3
Dependent Claim
22 words
A compound of claim 1, wherein A is represented by formula IIa or IIb wherein p is 0 and q is 1.
Claim 4
Dependent Claim
9 words
A compound of claim 1, wherein E is --NH--.
Claim 5
Dependent Claim
13 words
A compound of claim 1 wherein R 7 is hydrogen, methyl or aminobutyl.
Claim 6
Dependent Claim
10 words
A compound of claim 1 wherein R 3 is 2-pyridylethyl.
Claim 7
Dependent Claim
21 words
A compound of claim 1 wherein R 6 and R 8 are independently hydroxy, methoxy, ethoxy, phenoxyethoxy, pivaloyloxymethoxy, 1-glyceryl or ##STR42##
Claim 8
Dependent Claim
62 words
A compound of claim 1 wherein B is of the formula ##STR43## i.e., where J is --CH 2 ) s -- and s is 0-1, L is a bond or --Z--aryl-- wherein Z is a bond, and M is --((CH 2 ) t --X--(CH 2 ) v ), wherein t is 1, v is 1-2, and X is a bond or --O--.
Claim 9
Dependent Claim
11 words
A compound of claim 7 which is 1-[N-[3-[4-[[[6-chloro-3,4-dihydro-3-(2-pyridylethyl)-2H-1,2,4-benzothiadiazin-7-yl)sulfonylamino]methyl]phenyl]-1(S)-(ethoxycarbonyl)-propyl]-(S)-alanyl)-cis, syn-octahydroindole-2(S)-carboxylic acid, S,S-dioxide.
Claim 10
Dependent Claim
21 words
An antihypertensive pharmaceutical composition comprising an anthihypertensive effective amount of compound of claim 1 together with a pharmaceutically acceptable carrier therefor.
Claim 11
Dependent Claim
36 words
A method for reducing blood pressure in hypertensive mammals which comprises administering to a hypertensive mammal a composition comprising an antihypertensive effective amount of a compound of claim 1 together with a pharmaceutically acceptable carrier therefor.
Claim 12
Dependent Claim
390 words
A compound represented by the formula ##STR44## and the pharmaceutically acceptable salts thereof, wherein: A is ##STR45## l is 1 or 2; n is 0 or 1; p and q are 0, 1 or 2, provided that in structures IIb and IIc the sum of p and q is 1 or 2, and that in formula IId, p is not 0; B is --J--L--M--; D is ##STR46## E is --NH--, --O--, --S--, or --CH 2 --; G is --SO 2 --; J is --(CH 2 ) s -- or --((CH 2 ) t --W)--; L is a 5- or 6-membered heterocyclic radical comprising 3 to 5 carbon atoms and 1 or 2 heteroatoms selected from N, O and S, or a R 5 -substituted heterocycyclic radical M is --(CH 2 ) u -- or --((CH 2 ) t --X--(CH 2 ) v )--; W is ##STR47## X and Z are independently a chemical bond, ##STR48## s, u and v are independently 0-5; t is 1-5; R 1 , R 2 and R 9 are independently hydrogen, lower alkyl or lower acyl; R 3 is hydrogen, lower alkyl, haloloweralkyl, phenylloweralkyl, (cycloalkyl)loweralkyl, aminomethyl, loweralkylaminomethyl, phenyl(lower)alkylaminomethyl, (cycloalkyl)loweralkylthiomethyl, loweralkylthiomethyl or haloloweralkylthiomethyl; R 4 is chlorine or CF 3 ; R 5 is hydrogen, halogen, lower alkyl, lower acyl, lower alkxoy, haloloweralkyl or phenylloweralkyl; R 7 is hydrogen, lower alkyl or aminoloweralkyl; R 6 and R 8 are independently hydroxy, alkoxy having form 1 to 8 carbon atoms, benzyl, allkyl, R 10 --Q r --(CH 2 ) m --O--, wherein Q is oxygen or sulfur, r is 0 or 1 and m is 2 to 4, ##STR49## wherein the alkyl has from 3 to 8 carbon atoms, ##STR50## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR51## R 10 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 11 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 2 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenyl lower alkyl, wherein phenyl may be substituted by group T; and R 13 is hydrogen or lower alkyl.
Claim 13
Dependent Claim
390 words
A compound represented by the formula ##STR44## and the pharmaceutically acceptable salts thereof, wherein: A is ##STR45## l is 1 or 2; n is 0 or 1; p and q are 0, 1 or 2, provided that in structures IIb and IIc the sum of p and q is 1 or 2, and that in formula IId, p is not 0; B is --J--L--M--; D is ##STR46## E is --NH--, --O--, --S--, or --CH 2 --; G is --SO 2 --; J is --(CH 2 ) s -- or --((CH 2 ) t --W)--; L is a 5- or 6-membered heterocyclic radical comprising 3 to 5 carbon atoms and 1 or 2 heteroatoms selected from N, O and S, or a R 5 -substituted heterocycyclic radical M is --(CH 2 ) u -- or --((CH 2 ) t --X--(CH 2 ) v )--; W is ##STR47## X and Z are independently a chemical bond, ##STR48## s, u and v are independently 0-5; t is 1-5; R 1 , R 2 and R 9 are independently hydrogen, lower alkyl or lower acyl; R 3 is hydrogen, lower alkyl, haloloweralkyl, phenylloweralkyl, (cycloalkyl)loweralkyl, aminomethyl, loweralkylaminomethyl, phenyl(lower)alkylaminomethyl, (cycloalkyl)loweralkylthiomethyl, loweralkylthiomethyl or haloloweralkylthiomethyl; R 4 is chlorine or CF 3 ; R 5 is hydrogen, halogen, lower alkyl, lower acyl, lower alkxoy, haloloweralkyl or phenylloweralkyl; R 7 is hydrogen, lower alkyl or aminoloweralkyl; R 6 and R 8 are independently hydroxy, alkoxy having form 1 to 8 carbon atoms, benzyl, allkyl, R 10 --Q r --(CH 2 ) m --O--, wherein Q is oxygen or sulfur, r is 0 or 1 and m is 2 to 4, ##STR49## wherein the alkyl has from 3 to 8 carbon atoms, ##STR50## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR51## R 10 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 11 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 2 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenyl lower alkyl, wherein phenyl may be substituted by group T; and R 13 is hydrogen or lower alkyl.
Claim 14
Dependent Claim
22 words
A compound of claim 11 wherein A is represented by formula IIa or IIb wherein p is 0 and q is 1.
Claim 15
Dependent Claim
9 words
A compound of claim 11 wherein E is --NH--.
Claim 16
Dependent Claim
13 words
A compound of claim 11 wherein R 7 is hydrogen, methyl or aminobutyl.
Claim 17
Dependent Claim
9 words
A compound of claim 11 wherein L is 2-thiazolyl.
Claim 18
Dependent Claim
21 words
A compound of claim 11 wherein R 6 and R 8 are independently hydroxy, methoxy, ethoxy, phenoxyethoxy, pivaloyloxymethoxy, 1-glyceryl or ##STR52##
Claim 19
Dependent Claim
21 words
An antihypertensive pharmaceutical composition comprising an antihypertensive effective amount of compound of claim 11 together with a pharmaceutically acceptable carrier therefor.
Claim 20
Dependent Claim
36 words
A method for reducing blood pressure in hypertensive mammals which comprises administering to a hypertensive mammal a compostiion comprising an antihypertensive effective amount of a compound of claim 11 together with a pharmaceutically acceptable carrier therefor.
Claim 21
Dependent Claim
396 words
A compound represented by the formula ##STR53## and the pharmaceutically acceptable salts thereof, wherein: A is ##STR54## l is 1 or 2; n is 0 or 1; p and q are 0, 1 or 2, provided that in structures IIb and IIc the sum of p and q is 1 or 2, and that in formula IId, p is not 0; B is --J--L--M--; D is ##STR55## E is --NH--, --O--, --S--, or --CH 2 --; G is --SO 2 --; J is --(CH 2 ) s -- or --((CH 2 ) t --W)--; L is a 5- or 6-membered heterocyclic radical comprising 3 to 5 carbon atoms and 1 or 2 heteroatoms selected from N, O and S, or a R 5 -substituted heterocyclic radical; M is --(CH 2 ) u -- or --((CH 2 ) t --X--(CH 2 ) v )--; W is ##STR56## X and Z are independently a chemical bond, ##STR57## s, u and v are independently 0-5; t is 1-5; R 1 , R 2 and R 9 are indepently hydrogen, lower alkyl or lower acyl; R 3 is 2-, 3- or 4-pyridylloweralkyl, 2-, 4- or 5-thiazolylloweralkyl, 2-, 4- or 5-1H-imidazolylloweralkyl, 1-imidazolylloweralkyl, 1-morpholinoloweralkyl or hydroxyphenylloweralkyl; R 4 is chlorine or CF 3 ; R 5 is hydrogen, halogen, lower alkyl, lower acyl, lower alkoxy, haloloweralkyl or phenylloweralkyl; R 7 is hydrogen, lower alkyl or aminoloweralkyl; R 6 and R 8 are independently hydroxy, alkoxy having from 1 to 8 carbon atoms, benzyl, allyl, R 10 --Q r --(CH 2 ) m --O--, wherein Q is oxygen or sulfur, r is 0 or 1 and m is 2 to 4, ##STR58## wherein the alkyl has from 3 to 8 carbon atoms, ##STR59## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR60## R 10 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; are independently 0-5; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 11 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 12 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenyl lower alkyl, wherein phenyl may be substituted by group T; and R 13 is hydrogen or lower alkyl.
Claim 22
Dependent Claim
396 words
A compound represented by the formula ##STR53## and the pharmaceutically acceptable salts thereof, wherein: A is ##STR54## l is 1 or 2; n is 0 or 1; p and q are 0, 1 or 2, provided that in structures IIb and IIc the sum of p and q is 1 or 2, and that in formula IId, p is not 0; B is --J--L--M--; D is ##STR55## E is --NH--, --O--, --S--, or --CH 2 --; G is --SO 2 --; J is --(CH 2 ) s -- or --((CH 2 ) t --W)--; L is a 5- or 6-membered heterocyclic radical comprising 3 to 5 carbon atoms and 1 or 2 heteroatoms selected from N, O and S, or a R 5 -substituted heterocyclic radical; M is --(CH 2 ) u -- or --((CH 2 ) t --X--(CH 2 ) v )--; W is ##STR56## X and Z are independently a chemical bond, ##STR57## s, u and v are independently 0-5; t is 1-5; R 1 , R 2 and R 9 are indepently hydrogen, lower alkyl or lower acyl; R 3 is 2-, 3- or 4-pyridylloweralkyl, 2-, 4- or 5-thiazolylloweralkyl, 2-, 4- or 5-1H-imidazolylloweralkyl, 1-imidazolylloweralkyl, 1-morpholinoloweralkyl or hydroxyphenylloweralkyl; R 4 is chlorine or CF 3 ; R 5 is hydrogen, halogen, lower alkyl, lower acyl, lower alkoxy, haloloweralkyl or phenylloweralkyl; R 7 is hydrogen, lower alkyl or aminoloweralkyl; R 6 and R 8 are independently hydroxy, alkoxy having from 1 to 8 carbon atoms, benzyl, allyl, R 10 --Q r --(CH 2 ) m --O--, wherein Q is oxygen or sulfur, r is 0 or 1 and m is 2 to 4, ##STR58## wherein the alkyl has from 3 to 8 carbon atoms, ##STR59## wherein the phenyl may be substituted with group T defined below, 1-glyceryl, ##STR60## R 10 is phenyl, substituted phenyl wherein the substituents are chosen from group T, 1-naphthyl or 2-naphthyl; are independently 0-5; T is halogen, hydroxy, trifluoromethyl, lower alkoxy, lower alkyl, 2-furanyl, 3-furanyl, 2-thienyl, 3-thienyl, phenyl and substituted phenyl wherein the substituents are chosen from halogen, hydroxy, trifluoromethyl, lower alkoxy or lower alkyl; R 11 is hydrogen or alkyl having from 1 to 8 carbon atoms; R 12 is hydrogen, lower alkyl, unsubstituted or substituted phenyl and substituted or unsubstituted phenyl lower alkyl, wherein phenyl may be substituted by group T; and R 13 is hydrogen or lower alkyl.
Claim 23
Dependent Claim
22 words
A compound of claim 19 wherein A is represented by formula IIa or IIb wherein p is 0 and q is 1.
Claim 24
Dependent Claim
9 words
A compound of claim 19 wherein E is --NH--.
Claim 25
Dependent Claim
13 words
A compound of claim 19 wherein R 7 is hydrogen, methyl or aminobutyl.
Claim 26
Dependent Claim
21 words
A compound of claim 19 wherein R 6 and R 8 are independently hydroxy, methoxy, ethoxy, phenoxyethoxy, pivaloyloxymethoxy, 1-glyceryl or ##STR61##
Claim 27
Dependent Claim
21 words
An antihypertensive pharmaceutical composition comprising an antihypertensive effective amount of compound of claim 19 together with a pharmaceutically acceptable carrier therefor.
Claim 28
Dependent Claim
36 words
A method for reducing blood pressure in hypertensive mammals which comprises administering to a hypertensive mammal a composition comprising an anthihypetensive effective amount of a compound of claim 19 together with a pharmaceutically acceptable carrier therefor.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1992-05-01 | 1992-10-31 | 1993-05-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1996-05-01 | 1996-10-31 | 1997-05-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2000-05-01 | 2000-10-31 | 2001-05-02 | $7700.00 | Window Closed / Lapsed |